Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2020

01-02-2020 | Breast Cancer | Brief Report

Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer

Authors: Ximena García, Andrés Elía, Lucrecia Galizzi, María May, Eunice Spengler, Paula Martínez Vázquez, Javier Burruchaga, Hugo Gass, Claudia Lanari, Caroline A. Lamb

Published in: Breast Cancer Research and Treatment | Issue 1/2020

Login to get access
Metadata
Title
Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
Authors
Ximena García
Andrés Elía
Lucrecia Galizzi
María May
Eunice Spengler
Paula Martínez Vázquez
Javier Burruchaga
Hugo Gass
Claudia Lanari
Caroline A. Lamb
Publication date
01-02-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-020-05527-3

Other articles of this Issue 1/2020

Breast Cancer Research and Treatment 1/2020 Go to the issue

Epidemiology

Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients

Epidemiology

Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer

Letter to the Editor

Nationwide prevalence and trends of acute cardiovascular and cerebrovascular events among adult breast cancer survivors with a history of radiation therapy

Clinical trial

Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen

Epidemiology

Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy

Preclinical Study

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits